GLP-1 weight-management medications have become one of the most talked about trends in food and beverage innovation. While adoption is growing, usage remains far from mainstream and many consumers discontinue treatment due to cost, accessibility, side effects or achieving their health goals. The message from market researchers remains consistent: plan, don't panic.

What is becoming clear is that GLP-1 users are changing how they shop and eat. Research shows users typically purchase fewer indulgent and impulse items, and place greater emphasis on foods that deliver nutritional value, satiety and functionality. Smaller portion sizes, high-protein products, fibre-rich foods and convenient nutrient-dense formats are increasingly favoured as consumers seek to maximise nutrition while managing a reduced appetite.

This shift is reinforcing trends that were already gaining momentum across the broader market. Demand for protein, fibre, hydration, digestive health and metabolic wellness continues to grow, not only among GLP-1 users but also among consumers looking for proactive health solutions.

As a response to the increasing use of GLP-1s, product innovation is emerging around naturally supporting the body's own GLP-1 response. For example, Rousselot's Nextida® GC has demonstrated the ability to increase GLP-1 secretion and reduce post-meal glucose spikes, highlighting growing interest in ingredients that support metabolic health beyond pharmaceutical interventions.

For food and beverage manufacturers in ANZ, the opportunity may not lie in developing products exclusively for GLP-1 users, at least not yet. Instead, brands should focus on delivering higher nutrient density, satiety, metabolic health support and functional wellness benefits in formats that align with evolving consumer priorities. As GLP-1 adoption grows, these attributes are likely to become increasingly important across the wider population, creating opportunities for brands that are prepared to adapt early.